Samsara Therapeutics, Inc. is a biopharmaceutical company aiming to discover the first-in-class therapeutics that treat rare genetic and neurodegenerative diseases and extend a healthy lifespan. Samsara's platform is the largest ever pipeline for the identification, chemical optimization, and in vivo validation of compounds that enhance autophagy.

Biotechnology

Education

Samsara Therapeutics

Jens Eckstein

Natalia Pinzon

Matthew G. Williamson

Jakub Stefaniak

Nancy Malintan

James Taylor

Alkmini Kalousi

Marija Zecevic

Mark de Rosch

Oliver Kepp

Warren Galloway

John K. Blackwood

The Scientific Team at Samsara Therapeutics is responsible for conducting cutting-edge research to discover and optimize therapeutic compounds that enhance autophagy. They lead efforts in in vivo validation, leveraging their expertise in biology and chemistry to identify and develop treatments for rare genetic and neurodegenerative diseases. This team collaborates closely to push the boundaries of science and extend healthy lifespans through innovative drug discovery.

Scientific Team

Leadership Team

Scientific Team

About

Team members

Other teams at Samsara Therapeutics

Leadership Team